Published in Am J Med Genet A on July 20, 2012
The RASopathies. Annu Rev Genomics Hum Genet (2013) 2.06
Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci (2013) 1.00
Neurocognitive profiles of learning disabled children with neurofibromatosis type 1. Front Hum Neurosci (2014) 0.81
Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature. Cell Rep (2013) 0.81
Conclusions and future directions for the REiNS International Collaboration. Neurology (2013) 0.76
The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalon. J Neurosci (2014) 0.76
Pten regulates neuronal arborization and social interaction in mice. Neuron (2006) 6.11
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15
mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci (2009) 5.04
Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature (2011) 4.13
Two views of brain function. Trends Cogn Sci (2010) 3.26
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature (2002) 3.05
Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci (2009) 2.90
Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA (2009) 2.72
Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell (2008) 2.65
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol (2005) 2.62
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res (2003) 2.30
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA (2008) 2.30
Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28
A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature (2000) 2.27
The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci (2009) 2.12
Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet (2001) 2.10
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology (2005) 1.98
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development (2005) 1.85
Reversing neurodevelopmental disorders in adults. Neuron (2008) 1.80
A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet (1997) 1.71
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science (2001) 1.61
The molecular genetics of holoprosencephaly. Am J Med Genet C Semin Med Genet (2010) 1.57
Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet (2004) 1.49
Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci (2007) 1.44
Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol (2006) 1.42
Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med (2004) 1.39
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A (2010) 1.36
Impact of neurofibromatosis type 1 on school performance. J Child Neurol (2008) 1.27
Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity. J Neurosci (2010) 1.25
Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci (2008) 1.22
The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J Neurosci (2003) 1.21
Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatr Neurol (2011) 1.18
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet (2010) 1.18
Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. J Am Acad Child Adolesc Psychiatry (2008) 1.17
Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry (2010) 1.15
Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A (2010) 1.12
Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. J Neurosci (2007) 1.08
Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders. Mol Psychiatry (2009) 1.07
Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol (2004) 1.03
Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner. Mol Cell Neurosci (2011) 1.02
Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1. J Child Neurol (2010) 0.99
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry (2007) 0.98
Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn (1995) 0.95
Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. Neurosci Lett (2012) 0.95
Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype? Genet Med (2004) 0.94
Neurofibromatosis type 1: new insights into neurocognitive issues. Curr Neurol Neurosci Rep (2006) 0.94
PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Exp Neurol (2011) 0.94
Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann Neurol (1999) 0.94
Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants. J Neurosci (2012) 0.92
Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am J Med Genet A (2004) 0.91
Non-genetic risk factors for holoprosencephaly. Am J Med Genet C Semin Med Genet (2010) 0.89
A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol Psychiatry (2011) 0.89
Cognitive profile of children with neurofibromatosis and reading disabilities. Child Neuropsychol (2010) 0.88
Mental, motor, and language development of toddlers with neurofibromatosis type 1. J Pediatr (2010) 0.87
Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia. Am J Med Genet A (2010) 0.82
A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome. Transl Psychiatry (2011) 0.81
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 8.88
Competition between functional brain networks mediates behavioral variability. Neuroimage (2007) 6.98
The resting brain: unconstrained yet reliable. Cereb Cortex (2009) 6.20
Pten regulates neuronal arborization and social interaction in mice. Neuron (2006) 6.11
Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 5.89
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol (2008) 5.55
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell (2005) 5.51
The oscillating brain: complex and reliable. Neuroimage (2009) 5.22
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15
Mapping the functional connectivity of anterior cingulate cortex. Neuroimage (2007) 5.12
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci (2010) 5.12
Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science (2002) 5.08
Precuneus shares intrinsic functional architecture in humans and monkeys. Proc Natl Acad Sci U S A (2009) 4.99
Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci (2004) 4.99
Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Hum Brain Mapp (2009) 4.86
Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell (2009) 4.82
Reliable intrinsic connectivity networks: test-retest evaluation using ICA and dual regression approach. Neuroimage (2009) 4.47
The involvement of the anterior cingulate cortex in remote contextual fear memory. Science (2004) 4.29
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res (2002) 4.27
Development of anterior cingulate functional connectivity from late childhood to early adulthood. Cereb Cortex (2008) 4.12
TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron (2008) 4.00
Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res (2008) 3.99
A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics. Neuroimage (2013) 3.96
Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis. Neurosci Biobehav Rev (2007) 3.94
Functional connectivity of the human amygdala using resting state fMRI. Neuroimage (2008) 3.76
The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A (2005) 3.49
Neuronal competition and selection during memory formation. Science (2007) 3.48
Neurofibromatosis 2. Curr Opin Neurol (2003) 3.46
Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol (2002) 3.37
CREB required for the stability of new and reactivated fear memories. Nat Neurosci (2002) 3.28
Network centrality in the human functional connectome. Cereb Cortex (2011) 3.19
The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry (2006) 3.17
Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull (2007) 3.15
Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron (2008) 3.14
ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet (2003) 3.12
Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2006) 3.10
Broca's region: linking human brain functional connectivity data and non-human primate tracing anatomy studies. Eur J Neurosci (2010) 3.06
Neurofibromatosis type 1 revisited. Pediatrics (2009) 3.06
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature (2002) 3.05
Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res (2007) 3.05
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol (2014) 3.01
Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron (2005) 2.97
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet (2004) 2.97
Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp (2005) 2.93
Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci (2009) 2.90
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain (2007) 2.88
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell (2008) 2.84
Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev (2007) 2.80
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol (2007) 2.75
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res (2004) 2.75
Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy. J Neurosci (2010) 2.73
Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA (2009) 2.72
Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell (2013) 2.71
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol (2002) 2.65
Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell (2008) 2.65
Nf1 has an essential role in endothelial cells. Nat Genet (2002) 2.63
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol (2005) 2.62
CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nat Neurosci (2009) 2.60
Relationship between cingulo-insular functional connectivity and autistic traits in neurotypical adults. Am J Psychiatry (2009) 2.60
Network homogeneity reveals decreased integrity of default-mode network in ADHD. J Neurosci Methods (2007) 2.56
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res (2010) 2.56
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab (2006) 2.55
L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J Neurosci (2009) 2.55
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet (2007) 2.55
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54
Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry (2012) 2.44
The molecular and genetic basis of neurological tumours. Nat Rev Cancer (2002) 2.41
Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med (2002) 2.39
Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet (2005) 2.38
Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron (2004) 2.38
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry (2006) 2.36
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci (2003) 2.35
Functional brain correlates of social and nonsocial processes in autism spectrum disorders: an activation likelihood estimation meta-analysis. Biol Psychiatry (2008) 2.33
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol (2009) 2.32
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res (2003) 2.30
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA (2008) 2.30
Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology (2009) 2.29
Inter-individual differences in resting-state functional connectivity predict task-induced BOLD activity. Neuroimage (2010) 2.29
Brain development and ADHD. Clin Psychol Rev (2006) 2.28
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci (2006) 2.23
Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci (2007) 2.23
TrkB has a cell-autonomous role in the establishment of hippocampal Schaffer collateral synapses. J Neurosci (2005) 2.21
Aberrant striatal functional connectivity in children with autism. Biol Psychiatry (2010) 2.21
Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci (2002) 2.16
Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry (2012) 2.16
Whole-genome sequencing and intensive analysis of the undomesticated soybean (Glycine soja Sieb. and Zucc.) genome. Proc Natl Acad Sci U S A (2010) 2.15
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry (2014) 2.15
Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol (2007) 2.13